Skip to main content
SpringerLink
Log in

Quinolone Disposition in the Elderly

Practical Implications

  • Review Article
  • Clinical Pharmacology
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The fluoroquinolones are antibiotics frequently used in infections that affect elderly individuals. The physiological aging process can profoundly affect the pharmacokinetics of drugs, necessitating adjustment of dosage regimens in the elderly.

Changes in pharmacokinetics with age are mainly due to the progressive deterioration of renal function, with resultant lower clearance of drugs which are eliminated by the kidneys. Ofloxacin is almost totally renally excreted and elimination is slower in older age groups; a dose reduction is therefore recommended for this quinolone.

Unexpected alterations in pharmacokinetics may occur, as exemplified by the increased bioavailability of oral ciprofloxacin in elderly subjects. This is a well-documented phenomenon of such significance that lower oral doses are advisable for the elderly. Renal clearance of ciprofloxacin decreases in old age, but because of substantial nonrenal elimination the total clearance is affected less.

Studies of the pharmacokinetics of the other quinolones in old age are scarce. No data exist on the absolute oral bioavailability of norfloxacin, enoxacin and pefloxacin. Renal clearance seems to be reduced, but since no intravenous studies have been reported, the total and nonrenal clearances are unknown in the elderly. No safe conclusions can be drawn regarding the necessity of dose reductions from a pharmacokinetic point of view. However, reports of adverse reactions to quinolones in the elderly, especially concentration-dependent symptoms from the central nervous system, and the risk of interaction with other drugs, suggest the need for caution in determining dosages of all of these compounds in elderly subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bäck SE, Ljungberg B, Nilsson-Ehle I, Borgå O, Nilsson-Ehle P. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scandinavian Journal of Clinical and Laboratory Investigation 49: 641–646, 1989

    Article  PubMed  Google Scholar 

  • Ball AP, Fox C, Ball ME, Brown IRF, Willis JV. Pharmacokinetics of oral ciprofloxacin, 100mg single dose, in volunteers and elderly patients. Journal of Antimicrobial Chemotherapy 17: 629–635, 1986

    Article  PubMed  CAS  Google Scholar 

  • Barré J, Houin G, Tillement JP. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans. Journal of Pharmaceutical Sciences 73: 1379–1382, 1984

    Article  PubMed  Google Scholar 

  • Bayer A, Gajewska A, Stephens M, Stark J, Pathy J. Pharmacokinetics of ciprofloxacin in the elderly. Respiration 51: 292–295, 1987

    Article  PubMed  CAS  Google Scholar 

  • Chandler MHH, Toler SM, Rapp RP, Muder RR, Korvick JA. Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients. Antimicrobial Agents and Chemotherapy 34: 442–447, 1990

    Article  PubMed  CAS  Google Scholar 

  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41, 1976

    Article  PubMed  CAS  Google Scholar 

  • Davey PG. Overview of drug interactions with the quinolones. Journal of Antimicrobial Chemotherapy 22 (Suppl. C): 97–107, 1988

    PubMed  CAS  Google Scholar 

  • Davies DF, Shock NW. Age changes in GFR, effective RPF, and tubular excretory capacity in adult males. Journal of Clinical Investigation 29: 496–507, 1950

    Article  PubMed  CAS  Google Scholar 

  • Davies S, Graham PD, Spencer RC. Comparative in vitro activity of five fluoroquinolones against mycobacteria. Journal of Antimicrobial Chemotherapy 19: 605–609, 1987

    Article  PubMed  CAS  Google Scholar 

  • Dobbs BR, Gazeley LR, Campbell AJ, Edwards JR. The effect of age on the pharmacokinetics of enoxacin. European Journal of Clinical Pharmacology 33: 101–104, 1987

    Article  PubMed  CAS  Google Scholar 

  • Dow J, Frydman AM, Djebbar F, Gaillot J. Single- and multiple-dose pharmacokinetics of perfloxacin in elderly patients. Reviews of Infectious Diseases 10 (Suppl. 1): S107, 1988

    Google Scholar 

  • Drusano GL. An overview of the pharmacology of intravenously administered ciprofloxacin. American Journal of Medicine 82 (Suppl. 4a): 339–345, 1987

    PubMed  CAS  Google Scholar 

  • Frydman AM, Le Roux Y, Lefebvre MA, Djebbar F, Fourtillan JB, et al. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400mg BID) in young healthy volunteers. Journal of Antimicrobial Chemotherapy (Suppl. B): 65–79, 1986

    Google Scholar 

  • Guay DRP, Awni WM, Peterson PK, Obaid S, Stein D, et al. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients. International Journal of Clinical Pharmacology, Therapy and Toxicology 26: 279–284, 1988

    CAS  Google Scholar 

  • Henwood JM, Monk JP. Enoxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 36: 32–66, 1988

    Article  PubMed  CAS  Google Scholar 

  • Hirata CAI, Guay DRP, Awni WM, Stein DJ, Peterson PK. Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients. Antimicrobial Agents and Chemotherapy 33: 1927–1931, 1989

    Article  PubMed  CAS  Google Scholar 

  • Holmes B, Brogden RN, Richards DM, Norfloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 30: 482–513, 1985

    Article  PubMed  CAS  Google Scholar 

  • Humbert G, Borsa F, Couet W, Fourtillan JB, Vincent du Laurier M, et al. Pharmacokinetics of ofloxacin in healthy volunteers after oral administration. Abstract. 16th International Congress on Chemotherapy, Kyoto, Japan 1985

  • Kayser FH, Novak J. In vitro activity of ciprofloxacin against Gram-positive bacteria: an overview. American Journal of Medicine 82 (Suppl. 4A): 33–39, 1987

    PubMed  CAS  Google Scholar 

  • Kelly JG, Deaney NB, Lavan J, Boel J. Chronic dose urinary and serum pharmacokinetics of norfloxacin in the elderly. British Journal of Clinical Pharmacology 26: 787–790, 1988

    Article  PubMed  CAS  Google Scholar 

  • Klein U, Klein M, Sturm H, Rothenbühler M, Huber R, et al. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. International Journal of Clinical Pharmacology and Biopharmaceutics 13: 187–195, 1976

    CAS  Google Scholar 

  • LeBel M, Barbeau G, Bergeron MG, Roy D, Vallée F. Pharmacokinetics of ciprofloxacin in elderly subjects. Pharmacotherapy 6: 87–91, 1986

    PubMed  CAS  Google Scholar 

  • Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP. 1,8-naphthyridine derivatives: a new class of chemotherapeutic agents. Journal of Medicinal and Pharmaceutical Chemistry 5: 1063–1065, 1962

    Article  CAS  Google Scholar 

  • Ljungberg B, Nilsson-Ehle I. Pharmacokinetics of antimicrobial agents in the elderly. Reviews of Infectious Diseases 9: 250–264, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ljungberg B, Nilsson-Ehle I. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance. European Journal of Clinical Microbiology and Infectious Diseases 8: 515–520, 1989

    Article  CAS  Google Scholar 

  • Lode H, Höffken G, Olschewski P, Sievers B, Kirch A, et al. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrobial Agents and Chemotherapy 31: 1338–1342, 1987

    Article  PubMed  CAS  Google Scholar 

  • MacGowan AP, Greig MA, Clarke EA, White LO, Reeves DS. The pharmacokinetics of norfloxacin in the aged. Journal of Antimicrobial Chemotherapy 22: 721–727, 1988

    Article  PubMed  CAS  Google Scholar 

  • Monk JP, Campoli-Richards DM. Ofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 33: 346–391, 1987

    Article  PubMed  CAS  Google Scholar 

  • Naber KG, Sörgel F, Gutzler F, Bartosik-Wich B. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections. Infection 14 (Suppl. 3): S203–S208, 1986

    Article  PubMed  Google Scholar 

  • Naber KG, Sörgel F, Kees F, Jaehde U, Schumacher H. Brief report: pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration. American Journal of Medicine 87 (Suppl. 5A): 57S–59S, 1989

    Article  PubMed  CAS  Google Scholar 

  • National Board of Health and Welfare. Biverkningar av Lexinoren treårs-uppföljning. (In Swedish). Information från Social-styrelsens läkemedelsavdelning 14: 118–121, 1989

    Google Scholar 

  • Neu HC. Clinical use of the quinolones. Lancet 2: 1319–1322, 1987

    Article  PubMed  CAS  Google Scholar 

  • Paulsen O. The antibacterial activity, pharmacology and therapeutic application of ciprofloxacin. Drugs of Today 24: 361–401, 1988

    CAS  Google Scholar 

  • Raaof S, Wollschlager C, Khan FA. Ciprofloxacin increases serum levels of theophylline. American Journal of Medicine 82 (Suppl. 4A): 115–118, 1987

    Google Scholar 

  • Rademaker CMA, Jones RW, Van Dijk A, Glerum JH, Verhoef J. Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models. Pharmaceutisch Weekblad Scientific Edition 11: 224–228, 1989

    Article  PubMed  CAS  Google Scholar 

  • Siersbaek-Nielsen K, Mølholm Hansen J, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet 1: 1133–1134, 1971

    Article  PubMed  CAS  Google Scholar 

  • Sörgel F, Jaehde U, Naber K, Stephan U. Pharmacokinetics disposition of quinolones in human body fluids and tissues. Clinical Pharmacokinetics 16 (Suppl. 1): 5–24, 1989

    Article  PubMed  Google Scholar 

  • Veyssier P, Fourtillan JB, Modai J, Couet W, Lefebvre MA, et al. Pharmacokinetics of ofloxacin following a single oral 200-mg dose in elderly subjects (65 to 85 years) with normal renal function (in French). Pathologie Biologie 34: 596–599, 1986

    PubMed  CAS  Google Scholar 

  • Wise R, Baker SL, Misra M, Griggs D. The pharmacokinetics of enoxacin in elderly patients. Journal of Antimicrobial Chemotherapy 19: 343–350, 1987

    Article  PubMed  CAS  Google Scholar 

  • Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 28: 581–586, 1985

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, University Hospital of Lund, S-221 85, Lund, Sweden

    Ingrid Nilsson-Ehle & Bengt Ljungberg

Authors
  1. Ingrid Nilsson-Ehle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bengt Ljungberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson-Ehle, I., Ljungberg, B. Quinolone Disposition in the Elderly. Drugs & Aging 1, 279–288 (1991). https://doi.org/10.2165/00002512-199101040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199101040-00004

Keywords

Search

Navigation